12.79
price up icon0.43%   0.055
after-market アフターアワーズ: 12.80 0.01 +0.08%
loading
前日終値:
$12.73
開ける:
$12.58
24時間の取引高:
1.23M
Relative Volume:
0.49
時価総額:
$4.08B
収益:
$3.05B
当期純損益:
$181.32M
株価収益率:
34.23
EPS:
0.3737
ネットキャッシュフロー:
$225.64M
1週間 パフォーマンス:
-0.23%
1か月 パフォーマンス:
+7.93%
6か月 パフォーマンス:
+22.63%
1年 パフォーマンス:
+65.03%
1日の値動き範囲:
Value
$12.55
$12.85
1週間の範囲:
Value
$12.35
$13.03
52週間の値動き範囲:
Value
$7.02
$15.42

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
名前
Amneal Pharmaceuticals Inc
Name
セクター
Healthcare (1108)
Name
電話
908-947-3120
Name
住所
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
職員
5,210
Name
Twitter
@amnealpharma
Name
次回の収益日
2026-05-01
Name
最新のSEC提出書
Name
AMRX's Discussions on Twitter

Compare AMRX vs TAK, ZTS, HLN, TEVA, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
AMRX icon
AMRX
Amneal Pharmaceuticals Inc
12.79 4.06B 3.05B 181.32M 225.64M 0.3737
TAK icon
TAK
Takeda Pharmaceutical Co Adr
16.30 51.84B 29.85B 776.90M 4.35B 0.2408
ZTS icon
ZTS
Zoetis Inc
113.83 49.05B 9.47B 2.67B 2.28B 6.0218
HLN icon
HLN
Haleon Plc Adr
9.30 42.09B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
35.38 36.82B 17.41B 1.43B 1.00B 1.2182
UTHR icon
UTHR
United Therapeutics Corp
571.07 24.94B 3.18B 1.33B 1.04B 27.90

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-17 開始されました UBS Buy
2025-12-09 開始されました Barclays Overweight
2025-06-06 開始されました Goldman Buy
2025-02-24 アップグレード JP Morgan Neutral → Overweight
2024-09-06 アップグレード JP Morgan Underweight → Neutral
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2021-03-08 アップグレード Goldman Sell → Buy
2020-12-14 アップグレード Barclays Equal Weight → Overweight
2020-12-14 アップグレード Guggenheim Neutral → Buy
2020-07-27 開始されました Goldman Sell
2020-05-12 アップグレード Guggenheim Sell → Neutral
2019-12-12 ダウングレード Raymond James Outperform → Mkt Perform
2019-11-12 ダウングレード JP Morgan Neutral → Underweight
2019-11-07 ダウングレード SVB Leerink Outperform → Mkt Perform
2019-07-22 アップグレード SVB Leerink Mkt Perform → Outperform
2019-07-11 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2019-07-08 アップグレード Piper Jaffray Neutral → Overweight
2019-06-11 開始されました Barclays Equal Weight
2019-05-21 アップグレード Raymond James Mkt Perform → Strong Buy
2019-03-20 開始されました SunTrust Buy
2019-03-08 ダウングレード SVB Leerink Outperform → Mkt Perform
2018-12-14 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-10-16 ダウングレード SunTrust Buy → Hold
2018-08-13 アップグレード RBC Capital Mkts Sector Perform → Outperform
2018-07-23 開始されました Morgan Stanley Overweight
2018-06-22 開始されました B. Riley FBR, Inc. Buy
すべてを表示

Amneal Pharmaceuticals Inc (AMRX) 最新ニュース

pulisher
01:38 AM

Here's why Amneal Pharmaceuticals (AMRX) is a strong growth stock - MSN

01:38 AM
pulisher
12:59 PM

Amneal Pharmaceuticals (AMRX) is a top-ranked momentum stock: Should you buy? - MSN

12:59 PM
pulisher
12:45 PM

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

12:45 PM
pulisher
10:27 AM

AMRX: 3 growth drivers behind Amneal's 2026 outlook - MSN

10:27 AM
pulisher
09:55 AM

Wall Street Analysts See a 34.77% Upside in Amneal (AMRX): Can the Stock Really Move This High? - Yahoo Finance

09:55 AM
pulisher
09:40 AM

Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now? - Yahoo! Finance Canada

09:40 AM
pulisher
06:17 AM

Here's how AMRX is tapping GLP-1 demand through manufacturing - MSN

06:17 AM
pulisher
04:02 AM

AMRX Should I Buy - Intellectia AI

04:02 AM
pulisher
01:39 AM

Amneal to buy Kashiv in $750M deal; raises FY26 EPS outlook - MSN

01:39 AM
pulisher
Apr 28, 2026

AMRX growth drivers: Generics, biosimilars, and Crexont - MSN

Apr 28, 2026
pulisher
Apr 28, 2026

Amneal to Ring the Nasdaq Closing Bell on April 2, 2024 - Quantisnow

Apr 28, 2026
pulisher
Apr 28, 2026

Amneal 2026-2027 Upside From Biosimilars Scale - Zacks Investment Research

Apr 28, 2026
pulisher
Apr 28, 2026

AMRX Valuation: What 1.69x Sales Means for Investors - Yahoo Finance

Apr 28, 2026
pulisher
Apr 28, 2026

AMRX Growth Drivers: Generics, Biosimilars, and Crexont - Yahoo Finance Australia

Apr 28, 2026
pulisher
Apr 27, 2026

BlackRock (NYSE: AMRX) holds 24.1M shares, 7.6% stake reported - Stock Titan

Apr 27, 2026
pulisher
Apr 27, 2026

Amneal Pharma to acquire Kashiv BioSciences to create fully integrated global biosimilar leader - MSN

Apr 27, 2026
pulisher
Apr 27, 2026

Here's Why Amneal Pharmaceuticals (AMRX) is a Strong Growth Stock - Yahoo Finance

Apr 27, 2026
pulisher
Apr 26, 2026

Amneal initiates nationwide settlement for opioid-related claims - MSN

Apr 26, 2026
pulisher
Apr 26, 2026

Why Amneal Pharmaceuticals (AMRX) is a top growth stock for the long term - MSN

Apr 26, 2026
pulisher
Apr 26, 2026

Amneal rated buy in new research coverage at UBS as growth pipeline expands - MSN

Apr 26, 2026
pulisher
Apr 25, 2026

Assessing Amneal Pharmaceuticals (AMRX) Valuation After Strong Multi Year Returns And Recent Share Price Cooldown - Yahoo Finance

Apr 25, 2026
pulisher
Apr 25, 2026

Amneal Kashiv Deal Shifts Biosimilar Growth And Valuation Story - Sahm

Apr 25, 2026
pulisher
Apr 24, 2026

UBS initiates coverage of Amneal Pharmaceuticals (AMRX) with buy recommendation - MSN

Apr 24, 2026
pulisher
Apr 24, 2026

Amneal anticipates deleveraging below 3x by 2028 as it outlines $4.3B-$4.5B 2030 revenue target following Kashiv deal - MSN

Apr 24, 2026
pulisher
Apr 24, 2026

Amneal Acquires Kashiv BioSciences for $750 Million Upfront - HarianBasis.co

Apr 24, 2026
pulisher
Apr 24, 2026

Amneal Pharmaceuticals to Buy Kashiv BioSciences, Touts Strong Preliminary Q1 Results and Biosimilar Push - MarketBeat

Apr 24, 2026
pulisher
Apr 24, 2026

AMRX Price Today: Amneal Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 24, 2026
pulisher
Apr 23, 2026

2DT Stock Price and Chart — TRADEGATE:2DT - TradingView

Apr 23, 2026
pulisher
Apr 23, 2026

Why Is Amneal Pharmaceuticals Stock Gaining Today? - Sahm

Apr 23, 2026
pulisher
Apr 23, 2026

AMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary Results - The Globe and Mail

Apr 23, 2026
pulisher
Apr 23, 2026

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

Apr 23, 2026
pulisher
Apr 23, 2026

Amneal agrees to buy Kashiv BioSciences - The Pharma Letter

Apr 23, 2026

Amneal Pharmaceuticals Inc (AMRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.80
price down icon 1.58%
RDY RDY
$13.73
price down icon 2.14%
$131.23
price up icon 2.43%
RGC RGC
$28.95
price down icon 0.34%
$14.97
price up icon 1.01%
$571.07
price up icon 0.34%
大文字化:     |  ボリューム (24 時間):